Related Experiment Video
Updated: Jul 9, 2026

Using the Activity-based Anorexia Rodent Model to Study the Neurobiological Basis of Anorexia Nervosa
Published on: October 22, 2015
Psychopharmacological Prescribing Patterns Among Italian Adolescents With Anorexia Nervosa: Exploring Real-World
Marika Orlandi1,2, Arianna Vecchio2, Giulia Andorno1
1Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
Psychiatric comorbidities, not anorexia nervosa (AN) diagnosis, primarily drive psychotropic medication use in adolescents. However, AN patients showed higher benzodiazepine and polypharmacy rates, indicating unmet needs.
Area of Science:
- Child and Adolescent Psychiatry
- Clinical Psychology
- Psychopharmacology
Background:
- Anorexia nervosa (AN) is a complex eating disorder with significant psychiatric comorbidities.
- Understanding psychopharmacological prescribing patterns in adolescent AN is crucial for effective treatment.
- Real-world data on medication use in adolescent AN is limited, especially in diverse clinical settings.
Purpose of the Study:
- To compare psychopharmacological prescribing patterns in Italian adolescents with AN versus psychiatric controls.
- To determine if AN diagnosis independently predicts medication use, accounting for comorbidities.
- To investigate patterns of specific drug classes and polypharmacy in adolescent AN.
Main Methods:
- A cross-sectional cohort study of 298 female adolescents (12-18 years) from Italian Child and Adolescent Neuropsychiatry services.
- Participants were categorized into AN (n=149) and control (n=149) groups based on DSM-5/DSM-5-TR criteria.
- Multivariable logistic regression analyzed associations between diagnosis, medication use, and polypharmacy, adjusting for comorbidities and site differences.
Main Results:
- Unadjusted analyses showed higher psychotropic medication use in controls.
- AN diagnosis was not independently linked to overall psychotropic, antipsychotic, or antidepressant prescriptions.
- Adolescents with AN had significantly higher odds of receiving benzodiazepines (aOR=2.76) and polypharmacy (aOR=2.37).
- Polypharmacy was also associated with psychotic, personality, and depressive disorders.
Conclusions:
- Psychopharmacological treatment for adolescent AN is largely influenced by co-occurring psychiatric conditions.
- Increased benzodiazepine use and polypharmacy in AN suggest specific clinical needs.
- Further research is needed to develop evidence-based, disorder-specific pharmacological guidelines for adolescent AN.
More Related Videos
Related Concept Videos
Anorexia Nervosa
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Drug Therapy
Antianxiety Medications
Antidepressant Drugs: MAOIs and Other Agents
Psychosis: Goals of Pharmacotherapy
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
